Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-25 @ 6:57 PM
Study NCT ID:
NCT03475004
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2018-03-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Sponsor:
University of Colorado, Denver
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-14
First Submit QC Date:
None
Study First Post Date:
2018-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-31
Results First Submit QC Date:
None
Results First Post Date:
2022-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-28
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL